Ftse Mib
34.799,27
-0,83%
DAX
20.132,85
-0,44%
S&P 500
5.836,22
0,16%
NASDAQ
19.088,10
-0,38%
Bitcoin
95.090,00
0,62%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kiora Pharmaceuticals Inc (KPRX) Kiora Pharmaceuticals Inc (KPRX) Notizie

KPRX

Kiora Pharmaceuticals (KPRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KPRX
DataOraFonteTitoloSimboloCompagnia
13/11/202423:34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:KPRXKiora Pharmaceuticals Inc
08/11/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KPRXKiora Pharmaceuticals Inc
08/11/202413:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KPRXKiora Pharmaceuticals Inc
12/09/202412:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KPRXKiora Pharmaceuticals Inc
29/05/202421:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KPRXKiora Pharmaceuticals Inc
28/02/202422:40Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KPRXKiora Pharmaceuticals Inc
14/02/202422:55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KPRXKiora Pharmaceuticals Inc
14/02/202421:51Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KPRXKiora Pharmaceuticals Inc
13/10/202323:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KPRXKiora Pharmaceuticals Inc
01/09/202313:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KPRXKiora Pharmaceuticals Inc
10/08/202323:23Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KPRXKiora Pharmaceuticals Inc
21/07/202322:49Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KPRXKiora Pharmaceuticals Inc
11/07/202323:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:KPRXKiora Pharmaceuticals Inc
23/06/202314:35GlobeNewswire Inc.Life Science Investor Forum: Presentations Now Available for Online ViewingNASDAQ:KPRXKiora Pharmaceuticals Inc
21/06/202322:25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KPRXKiora Pharmaceuticals Inc
20/06/202316:58GlobeNewswire Inc.Life Science Investor Forum Agenda Announced for June 22ndNASDAQ:KPRXKiora Pharmaceuticals Inc
13/06/202322:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KPRXKiora Pharmaceuticals Inc
02/06/202323:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(1) (424b1)NASDAQ:KPRXKiora Pharmaceuticals Inc
01/06/202312:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:KPRXKiora Pharmaceuticals Inc
15/05/202323:28Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:KPRXKiora Pharmaceuticals Inc
09/05/202313:00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KPRXKiora Pharmaceuticals Inc
05/05/202323:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:KPRXKiora Pharmaceuticals Inc
28/04/202320:20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KPRXKiora Pharmaceuticals Inc
23/03/202312:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:KPRXKiora Pharmaceuticals Inc
13/02/202322:48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:KPRXKiora Pharmaceuticals Inc
13/02/202322:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KPRXKiora Pharmaceuticals Inc
29/12/202212:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KPRXKiora Pharmaceuticals Inc
22/11/202219:55TipRanksKiora Pharmaceuticals (KPRX) Receives a Hold from Maxim GroupNASDAQ:KPRXKiora Pharmaceuticals Inc
14/11/202212:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Kiora Pharmaceuticals (KPRX)NASDAQ:KPRXKiora Pharmaceuticals Inc
10/11/202220:05TipRanksMaxim Group Reaffirms Their Hold Rating on Kiora Pharmaceuticals (KPRX)NASDAQ:KPRXKiora Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:KPRX

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
CPR
Davide Campari
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
NEXI
Nexi S.p.A
BIT
PRY
Prysmian
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network